Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00198770 · ClinicalTrials.gov registry record · NA

Dietary Compensation With Substitution of Meat Products With White Button Mushrooms.

A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
55
Enrollment target

NCT00198770: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT00198770 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00198770, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

Unfortunately, current methods of achieving weight control are disappointing. There is also a great deal of public confusion over what constitutes an appropriate diet for weight control; there is a paucity of carefully performed, randomized, controlled clinical treatment trials to evaluate the varying opinions. Mushrooms are not widely appreciated as the nutritious, low calorie, low fat food (and potential meat substitute) that they are. Mushrooms may be a new "diet food," especially as a substitute for higher calorie and fat staples like meat. This study examines whether there is compensation for the potential calorie and fat savings of substituting mushrooms for meat in dishes over a 4-day period.

Interventions

  • DIETARY_SUPPLEMENT dietary substitution to assess level of caloric compensation

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2006-03
Est. Completion 2006-12
Phase NA

What the finished NCT00198770 record still lists

NCT00198770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which dietary substitution to assess level of caloric compensation is the first listed.

NCT00198770 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00198770 about?

NCT00198770 is a clinical study titled "Dietary Compensation With Substitution of Meat Products With White Button Mushrooms.". Unfortunately, current methods of achieving weight control are disappointing. There is also a great deal of public confusion over what constitutes an appropriate diet for weight control; there is a paucity of carefully performed, randomized, controlled clinical treatment trials to evaluate the varyi...

What is the current status of trial NCT00198770?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2006-03. Estimated completion is 2006-12.

What interventions are being tested in trial NCT00198770?

The interventions under investigation include: dietary substitution to assess level of caloric compensation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00198770?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00198770's enrollment target sits among peer trials

55 1264th of 2000 higher than 733 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00198770, the US trial registry maintained by the National Library of Medicine. NCT00198770 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.